SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-005809
Filing Date
2017-05-24
Accepted
2017-05-24 16:05:29
Documents
2
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k052417_therapix.htm 6-K 9208
2 PRESS RELEASE f6k052417ex99i_therapix.htm EX-99.1 6100
  Complete submission text file 0001213900-17-005809.txt   16309
Mailing Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501
Business Address 5 AZRIELI CENTER (SQUARE TOWER) TEL-AVIV L3 6702501 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 17866724
SIC: 2834 Pharmaceutical Preparations